Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155336 · ClinicalTrials.gov registry record · Phase 1
The Effects of Lovaza® in Acute Myocardial Infarction
A Phase 1 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01155336: Clinical Trial Phase 1 study, sponsored by University of Rochester.
NCT01155336 is a Phase 1 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01155336, a Phase 1 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will explore the safety and effectiveness of adding Lovaza® to the therapeutic program utilized internationally for the treatment of individuals with acute coronary syndromes.
Primary Outcome
Platelet function will be measured with PFA-100 test which has been shown to correlate with an increased risk for cardiovascular events in several well conducted studies and in a meta-analysis. The PFA-100 measures the number of seconds required for a clot to form in whole blood which is passed through an aperture in a cartridge coated with epinephrine. It is meant to imitate clotting in human arteries.
Interventions
- DRUG Lovaza®
- DRUG The placebo contained 1 gram of corn oil in each capsule.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-05 |
| Phase | Phase 1 |
Why NCT01155336 stopped before completion
NCT01155336 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Lovaza® is the first listed.
NCT01155336 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01155336 about?
NCT01155336 is a clinical study titled "The Effects of Lovaza® in Acute Myocardial Infarction". This study will explore the safety and effectiveness of adding Lovaza® to the therapeutic program utilized internationally for the treatment of individuals with acute coronary syndromes.
What is the current status of trial NCT01155336?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2010-06. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01155336?
The interventions under investigation include: Lovaza® (DRUG), The placebo contained 1 gram of corn oil in each capsule. (DRUG).
Who is sponsoring clinical trial NCT01155336?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01155336's enrollment target sits among peer trials
4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia